BAIJIN LIFE SCI completed the issuance of 65.3594 million subscription shares
智通財經 APP 訊，佰金生命科學發佈公告，根據公司股東於 2024 年 9 月 30 日批准的一般授權， 於 2025 年 4 月 3 日發行 6535.94 萬股新股份。
智通財經 APP 訊，佰金生命科學 (01466) 發佈公告，根據公司股東於 2024 年 9 月 30 日批准的一般授權， 於 2025 年 4 月 3 日發行 6535.94 萬股新股份。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments